Elisabet Johansson1, Jocelyn M Biagini2, Lisa J Martin3, Hua He4, John W Kroner1, Cassandra Almasri1, Veronica Velasquez1, Maud Sonzogni1, Stanley B DeVore1, Daniel Spagna1, Brittany Grashel1, Gurjit K Khurana Hershey5. 1. Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. 2. Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio. 3. Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio; Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. 4. Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. 5. Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio. Electronic address: gurjit.hershey@cchmc.org.
Abstract
BACKGROUND: In addition to its involvement in both the innate and adaptive immune systems, vitamin D has been found to affect keratinocyte function and proliferation, suggesting a possible role for vitamin D in cutaneous allergic sensitization. OBJECTIVE: To explore the role of circulating vitamin D levels in allergic sensitization. METHODS: Serum 25-hydroxyvitamin D (25(OH)D) levels were measured in a subset of children (N = 323) enrolled in the Mechanisms of Progression of Atopic Dermatitis to Asthma in Children cohort, a prospective early life cohort of children with atopic dermatitis. Allergic sensitization was determined using skin prick testing, and FLG expression in the keratinocytes was measured by quantitative polymerase chain reaction. Multiple Poisson regression was used to evaluate interaction effects between serum 25(OH)D levels and FLG expression with sensitization load as the outcome. RESULTS: Black participants had significantly lower mean levels of serum 25(OH)D compared with non-Black participants (29.3 vs 32.9 ng/mL; P < .001). FLG expression and sensitization load were negatively correlated in non-Black participants with 25(OH)D levels less than 27.2 ng/mL (Rho = -0.45; P = .02). No association between FLG expression and sensitization load was found in Black participants or participants with 25(OH)D levels greater than or equal to 27.2 ng/mL. Multiple Poisson regression models confirmed that 25(OH)D levels interact with FLG expression to affect sensitization load in non-Black participants. CONCLUSION: Despite lower vitamin D levels in Black participants, sensitization load was associated with nonlesional skin FLG expression in non-Black, but not Black, children with low vitamin D levels. Thus, a complex interplay of factors determines the impact of vitamin D on allergic sensitization.
BACKGROUND: In addition to its involvement in both the innate and adaptive immune systems, vitamin D has been found to affect keratinocyte function and proliferation, suggesting a possible role for vitamin D in cutaneous allergic sensitization. OBJECTIVE: To explore the role of circulating vitamin D levels in allergic sensitization. METHODS: Serum 25-hydroxyvitamin D (25(OH)D) levels were measured in a subset of children (N = 323) enrolled in the Mechanisms of Progression of Atopic Dermatitis to Asthma in Children cohort, a prospective early life cohort of children with atopic dermatitis. Allergic sensitization was determined using skin prick testing, and FLG expression in the keratinocytes was measured by quantitative polymerase chain reaction. Multiple Poisson regression was used to evaluate interaction effects between serum 25(OH)D levels and FLG expression with sensitization load as the outcome. RESULTS: Black participants had significantly lower mean levels of serum 25(OH)D compared with non-Black participants (29.3 vs 32.9 ng/mL; P < .001). FLG expression and sensitization load were negatively correlated in non-Black participants with 25(OH)D levels less than 27.2 ng/mL (Rho = -0.45; P = .02). No association between FLG expression and sensitization load was found in Black participants or participants with 25(OH)D levels greater than or equal to 27.2 ng/mL. Multiple Poisson regression models confirmed that 25(OH)D levels interact with FLG expression to affect sensitization load in non-Black participants. CONCLUSION: Despite lower vitamin D levels in Black participants, sensitization load was associated with nonlesional skin FLG expression in non-Black, but not Black, children with low vitamin D levels. Thus, a complex interplay of factors determines the impact of vitamin D on allergic sensitization.
Authors: Adriana J van Ballegooijen; Cassianne Robinson-Cohen; Ronit Katz; Michael Criqui; Matthew Budoff; Dong Li; David Siscovick; Andy Hoofnagle; Steven J Shea; Gregory Burke; Ian H de Boer; Bryan Kestenbaum Journal: Bone Date: 2015-05-11 Impact factor: 4.398
Authors: Srimathi Kannan; Matthew S Perzanowski; Harish B Ganguri; Dolores Acevedo-Garcia; Luis M Acosta; Molly Spatcher; Adnan Divjan; Ginger L Chew Journal: Ann Allergy Asthma Immunol Date: 2018-01 Impact factor: 6.347
Authors: Ji Hyeon Baek; Youn Ho Shin; In Hyuk Chung; Hae Jung Kim; Eun-Gyong Yoo; Jung Won Yoon; Hye Mi Jee; Young Eun Chang; Man Yong Han Journal: J Pediatr Date: 2014-08-06 Impact factor: 4.406
Authors: Simon Hsu; Andrew N Hoofnagle; Deepak K Gupta; Orlando M Gutierrez; Carmen A Peralta; Steven Shea; Norrina B Allen; Gregory Burke; Erin D Michos; Joachim H Ix; David Siscovick; Bruce M Psaty; Karol E Watson; Bryan Kestenbaum; Ian H de Boer; Cassianne Robinson-Cohen Journal: J Clin Endocrinol Metab Date: 2020-12-01 Impact factor: 5.958
Authors: Tea Skaaby; Lise Lotte Nystrup Husemoen; Torben Martinussen; Jacob P Thyssen; Michael Melgaard; Betina Heinsbæk Thuesen; Charlotta Pisinger; Torben Jørgensen; Jeanne D Johansen; Torkil Menné; Berit Carlsen; Pal B Szecsi; Steen Stender; Runa Vavia Fenger; Mogens Fenger; Allan Linneberg Journal: PLoS One Date: 2013-02-27 Impact factor: 3.240